Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

19981,436 citationsJournal Articlebronze Open Access

Authors

Abstract

Inhibition of platelet aggregation with eptifibatide reduced the incidence of the composite end point of death or nonfatal myocardial infarction in patients with acute coronary syndromes who did not have persistent ST-segment elevation.

Topics & Keywords

Acute Myocardial Infarction Research Antiplatelet Therapy and Cardiovascular Diseases Heparin-Induced Thrombocytopenia and Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 339, Issue 7, pp. 436-443

DOI: 10.1056/nejm199808133390704

Field-Weighted Citation Impact: 94.27